The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Growth Is Projected For The Joint Pain Injections Market During The Forecast Period 2026–2030?
The joint pain injections market size has experienced swift expansion in recent years. It is projected to grow from $6.12 billion in 2025 to $6.89 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.5%. The historical growth of this market can be attributed to the escalating prevalence of arthritis and joint disorders, the aging global population, a rising demand for minimally invasive pain treatments, increasing awareness of regenerative therapies, and the expansion of orthopedic specialty care.
The joint pain injections market size is anticipated to undergo significant expansion in the coming years, with projections indicating it will attain a value of $10.96 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.3%. This growth during the forecast period is propelled by factors such as the increasing integration of biologic pain therapies, a rising emphasis on personalized medicine, the enlargement of sports injury management, heightened investments in regenerative medicine, and a growing inclination towards non-opioid pain management techniques. Noteworthy trends for this period encompass a rise in the adoption of non-surgical pain management interventions, increased application of hyaluronic acid and PRP injections, a burgeoning demand for tailored pain treatment strategies, the expansion of regenerative medicine-based injectable solutions, and an enhanced focus on outpatient pain relief methods.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6482&type=smp
Which Major Factors Are Driving The Expansion Of The Joint Pain Injections Market?
The increasing occurrence of arthritis and musculoskeletal disorders is set to boost the expansion of the joint pain injections market. Globally, musculoskeletal disorders represent the leading cause of disability, with low back pain alone being the most frequent source of impairment across 160 nations. Individuals often receive injections to manage pain and alleviate inflammatory conditions. Illustratively, in August 2023, the Institute for Health Metrics and Evaluation (IHME), a U.S.-based independent health research organization, indicated that close to 1 billion individuals are anticipated to suffer from osteoarthritis by 2050. Consequently, the growing prevalence of arthritis and musculoskeletal disorder acts as a key driver for the joint pain injections market.
What Market Segments Are Evaluated Within The Joint Pain Injections Market?
The joint pain injections market covered in this report is segmented –
1) By Type Of Injection: Steroid Joint Injection, Hyaluronic Acid Injections
2) By Joint Type: Hip Joint, Knee And Ankle, Shoulder And Elbow, Facet Joints Of The Spine, Other Joint Types
3) By Distribution channel: Hospital Pharmacies, Retail Pharmacies
Subsegments:
1) By Steroid Joint Injection: Corticosteroid Injections, Combination Steroid Injections
2) By Hyaluronic Acid Injections: Single-Dose Hyaluronic Acid Injections, Multi-Dose Hyaluronic Acid Injections
What Industry Trends Are Redefining The Joint Pain Injections Market?
Major companies in the joint pain injections market are concentrating on developing innovations, such as single-injection formulations, which prioritize patient convenience. A single-injection formulation is defined as a drug delivery system designed to administer a precise medication dose in one injection, delivering sustained therapeutic effects over an extended period without requiring multiple doses. For instance, in July 2024, LG Chem Ltd., a chemicals company based in South Korea, launched Synovian, a new treatment for knee osteoarthritis in China that features a convenient single-injection formulation, making it the first of its kind in the country. This product aims to penetrate a significant market estimated at around KRW 200 billion (approximately USD 150 million). Developed using its proprietary technology, it demonstrates innovation in meeting patient needs. The emphasis is on delivering effective relief with minimal administration effort.
Who Are The Top Market Participants Influencing The Joint Pain Injections Market?
Major companies operating in the joint pain injections market are Seikagaku Corporation, Anika Therapeutics Inc., Bioventus Inc., Flexion Therapeutics Inc., Ferring Pharmaceuticals Inc., Sanofi S.A., AbbVie Inc., Pfizer Inc., Teva Pharmaceutical Industries Limited, Merck & Co. Inc., Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Limited, Wockhardt Ltd., Mallinckrodt Pharmaceuticals Ltd., Mylan N.V., Bayer AG, Eli Lilly and Company, Ipsen SA, Takeda Pharmaceutical Company Limited, AstraZeneca plc
Read the full joint pain injections market report here:
https://www.thebusinessresearchcompany.com/report/joint-pain-injections-global-market-report
Which Region Currently Holds The Largest Share Of The Joint Pain Injections Market?
North America was the largest region in the joint pain injections market in 2025. The regions covered in the joint pain injections market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Joint Pain Injections Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=6482&type=smp
Browse Through More Reports Similar to the Global Joint Pain Injections Market 2026, By The Business Research Company
Pain Management Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report
Bone And Joint Health Supplements Market Report 2026
Non Opioid Pain Patch Market Report 2026
https://www.thebusinessresearchcompany.com/report/non-opioid-pain-patch-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model